W HILE animal studies have demonstrated that digitalis enhances the force of contraction of the nonfailing heart,'X the effects of this agent on ventricular contractility of the normal human heart are as yet unsettled. In the absence of clinical heart failure, digitalis administration is associated with either a slight decrease -9 or no significant change in cardiac output.10-'4 Such observations have led to a widely held clinical impression that digitalis exerts its salutary effects only in the failing human heart 15, 16 and may even exert an adverse influence on the contractility of the normal heart.17 In contrast, Braunwald, Bloodwell, Goldberg, and Morrow,18 employing direct measures of ventricular tension during thoracotomy in individuals without heart failure, have offered strong evidence favoring the stimulatory effect of digitalis on the nonfailing heart.
In 1927, in their studies on the cardiodynamic actions of digitalis and g-strophanthidin, Wiggers and Stimson 19 demonstrated that the increased myocardial systolic force induced by digitalis is associated with a shortening in the duration of mechanical systole. A similar decrease in the duration of mechanical systole accompanying the positive inotropic effect of digitalis has been observed by Cotten and Bay,3 who noted a linear relationship between the myocardial force and the decrease in the duration of the isometric pressure gradient.
The present studies were undertaken in an attempt to determine whether deslanoside (Cedilanid-D) exerts comparable effects on the duration of mechanical systole in the normal human ventricle.
Method
All of the individuals studied were normal male university students in the age range of 22 to 28 years. The studies were begun in the morning after overnight fasting and all observations were made in the supine position.
In the hemodynamic observations cardiac output was determined by the indicator-dilution technic with use of central injections of indocyaninegreen dye through a polyethylene catheter (PE50) advanced to the right ventricle and withdrawn under pressure-monitoring to the right atrium. Arterial blood from a brachial artery was sampled continuously through a Cuvette Densitometer with a constant-rate motor-driven syringe (Gilford Instruments). Arterial pressures were derived from the brachial artery with a Statham P23Db transducer. All hemodynamic observations were performed in triplicate in both the control state and after digitalis.
The duration of left ventricular ejection was derived from the externally recorded carotid arteriogram with a ftunnel-shaped pick-un (2.3 cm. in diameter) and a Statham P23Db transducer as described previously.20 Recordings of the carotid arterial pulse were made simultaneously with the heart sounds and a standard electrocardiogram (lead II) at a paper speed of 100 mm. per second, with time markers indicating 0.02 second. The left ventricular ejection time (LVET) was meassured as the interval from the beginning upstroke to the trough of the incisura of the carotid arterial pulse tracing. At least 10 consecutive pulses were recorded and averaged for each determination. Heart rate was derived from the relationship 60/ average R-R. The left ventricular ejection time determined in this manner agrees closely with that derived from central aortic pressure tracings. + p is the significance of (lifference following dleslanoside. BSA, body suirface area; LVET, left ventricular ejection time, ETI, ejection time index; S1-S2, interval between the first and second heart sounds; ICT, calculated isometric contraction time (S1-S) -(LVET); S, systolic pressuire; D, diastolic pressure. NI, mean arterial pressure; MRLVE, mean rate of left ventricular ejection (SV/LVET). Hernodynantic response to dleslanoside in seven rate; SI, stroke index; ETI, ejection time indcex.
Deslaiioside administration was associated with no significant change in cardiac output. Heart rate slowed in each subject with a consequent increase in stroke volume. Mean arterial pressure rose slightly in all of the subjects. Despite the slowing of the heart rate, the S1-S2 interval decreased in six of the subjects. The ejection time index (left ventricular ejection time corrected for heart rate) fell consistently in all subjects. The estimated isometric contraction time, derived by subtraction of the left ventricular ejection time from the S1-S2 interval, decreased slightly in all of the subjects. The 2. Deslanoside administration was followed by a prompt decrease in the ejection time index, which was apparent at 10 minutes, reached minimum levels at 2 to 4 hours, and remained at a low level for 8 hours. Significant diminution in the ejection time index persisted for 72 hours following deslanoside ( fig. 2) .
Heart rate diminished significantly during the first 4 hours following deslanoside (table  2) . No significant bradyeardia accompanied the decrease in the ejection time index after the first 4 hours. In studies on three additional subjects the relative bradycardia induced by deslanoside was abolished with small intravenous doses of atropine 2 hours following the In order to test the specificity of the decreased ejection time index as an index of digitalis effect, the relationship between the effect of deslanoside during the first 8 hours after drug administration and dose level was studied in six subjects. Each subject received in random administration, at intervals of 3 weeks, 0.4 mg., 0.8 mg., and 1.6 mg. of deslanoside, intravenously. In addition, a placebo composed of deslanoside diluent was administered to each subject. Observations on heart rate and ejection time index were imade in the control state and at intervals for 8 figure 3 .
Following placebo administration the ejection time index tended to decrease slightly during the first 8 hours (average -5 msec., p<0.001). When compared to the placebo levels, the decreases in ejection time index following 0.4 mg., 0.8 mg., and 1.6 mg. were significant (p<0.01). When the relative effects of the dose levels were compared after subtraction of the placebo effect, the average response following 0.4 mg. of deslanoside was 42 per cent of the 1.6-rng. dose, while 0.8 mg.
evoked an effect 67 per cent of that of the 1.6-mg. dose.
Discussion
Previous studies on the determinants of the duration of ventricular ejection have demonstrated an inverse relationship with heart rate Circ lation, Voa/-7ne XXIX, May 1964 duces a diminution in duiration of ejection and lhence an increase in mean rate of left ventricuilar ejection. In these studies an increase in nean aortic pressure, approximating 100 mm.
Hg, induced shortening of the left ventricular ejection time of 45 msec. In view of the present observations of an increase in mean arterial pressure following deslanoside one must consider whether the enhanced rate of ejection may result primarily from the effect of the drug on left ventricular outflow resistance. Since the changes in mean arterial pressure following deslanoside were slight (average + 6 mm. Hg) they would appear to contribute only minimally to the clhanges in left ventricular ejection time and mean ejection rate. It is notable that the effect of digitalis on the normal ventricle remains uinexpressed in the minute outptut of the heart. It wouild appear that the regulatory role of the autonomic nervous system in maintaining constancy of the minute volume of the heart in the normal individual can conceal the positive inotropic influence of this agent if only the determination of cardiac output is considered. Measurement of the dturation of ventricuilar ejection together with the cardiac output lends a more specific approach to the detection of such positive inotropic influences. Heart rate slowed in most subjects following deslanoside. The observation of a decrease in the duration of ventricular ejection when the vagal effects were neutralized spontaneously and after atropine administration would 
